LEADER 03375nam  22005775  450 
001 9910253867303321
005 20200629160857.0
010   $a981-10-0791-8
024 7 $a10.1007/978-981-10-0791-0
035   $a(CKB)3710000000717861
035   $a(DE-He213)978-981-10-0791-0
035   $a(MiAaPQ)EBC6315023
035   $a(MiAaPQ)EBC5578795
035   $a(Au-PeEL)EBL5578795
035   $a(OCoLC)1066195121
035   $a(PPN)19407563X
035   $a(EXLCZ)993710000000717861
100   $a20160511d2016      u|         0
101 0 $aeng
135   $aurnn|008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aPharmaceutical Nanotechnology $eFundamentals and Practical Applications /$fby Costas Demetzos
205   $a1st ed. 2016.
210  1$aSingapore :$cSpringer Singapore :$cImprint: Adis,$d2016.
215   $a1 online resource (XXVIII, 203 p. 44 illus., 17 illus. in color.) 
311   $a981-10-0790-X 
327   $aPart I -- 1. Introduction to Nanotechnology -- 2. Fundamentals of Physical Pharmacy: The Biophysics of Nanosystems -- Part II -- 3. Application of Nanotechnology in Imaging and Diagnostics -- 4. Application of Nanotechnology in Drug Delivery and Targeting -- Part III -- 5. Application of Nanotechnology in Modified Release Systems -- 6. Nano- and Bio- Toxicity -- 7. Regulatory Framework for Nanomedicines.
330   $aThis textbook explains the fundamental aspects of nanotechnology and fills the gap between bio-inspired nanotechnological systems and functionality of living organisms, introducing new insights to their physicochemical, biophysical and thermodynamic behaviour. Addressed to all those involved in recent advances in pharmaceutics, this book is divided in three major parts: Part A refers to the physicochemical and thermodynamics aspects of nanosystems, wherein their biophysical behaviour is correlated with that of the cells of living organisms; Part B refers to the application of nanotechnology in imaging, diagnostics and therapeutics; Part C is focused on issues regarding safety and nanotoxicity of nanosystems, and the regulatory framework that surrounds these. The text promotes the concept that biophysics, thermodynamics and nanotechnology are considered to be emerging tools that, when approached within regulatory boundaries, provide new and integrated knowledge for the production of new medicines.
606   $aPharmaceutical technology
606   $aPharmacy
606   $aChemotherapy
606   $aPharmaceutical Sciences/Technology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21010
606   $aPharmacy$3https://scigraph.springernature.com/ontologies/product-market-codes/F00008
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
615  0$aPharmaceutical technology.
615  0$aPharmacy.
615  0$aChemotherapy.
615 14$aPharmaceutical Sciences/Technology.
615 24$aPharmacy.
615 24$aPharmacotherapy.
676   $a615.19
700   $aDemetzos$b Costas$4aut$4http://id.loc.gov/vocabulary/relators/aut$01061091
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910253867303321
996   $aPharmaceutical Nanotechnology$92517487
997   $aUNINA